Masja Straetemans

1.5k total citations
44 papers, 1.0k citations indexed

About

Masja Straetemans is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Masja Straetemans has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 12 papers in Infectious Diseases and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Masja Straetemans's work include Pneumonia and Respiratory Infections (12 papers), Tuberculosis Research and Epidemiology (8 papers) and Ear Surgery and Otitis Media (8 papers). Masja Straetemans is often cited by papers focused on Pneumonia and Respiratory Infections (12 papers), Tuberculosis Research and Epidemiology (8 papers) and Ear Surgery and Otitis Media (8 papers). Masja Straetemans collaborates with scholars based in Netherlands, Sweden and United States. Masja Straetemans's co-authors include Gerhard A. Zielhuis, Anne GM Schilder, Philippe Glaziou, Roger Damoiseaux, Marieke J. van der Werf, Ana Luiza Bierrenbach, Reinier H. Veenhoven, Elisabeth A. M. Sanders, Ger T. Rijkers and J.M. ten Cate and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Cochrane Database of Systematic Reviews.

In The Last Decade

Masja Straetemans

43 papers receiving 977 citations

Peers

Masja Straetemans
Teresa Brown Australia
R Hurley United Kingdom
Alicia M. Siston United States
Géraldine Hall United States
Micaela Gal United Kingdom
Masja Straetemans
Citations per year, relative to Masja Straetemans Masja Straetemans (= 1×) peers Grant Mackenzie

Countries citing papers authored by Masja Straetemans

Since Specialization
Citations

This map shows the geographic impact of Masja Straetemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masja Straetemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masja Straetemans more than expected).

Fields of papers citing papers by Masja Straetemans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masja Straetemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masja Straetemans. The network helps show where Masja Straetemans may publish in the future.

Co-authorship network of co-authors of Masja Straetemans

This figure shows the co-authorship network connecting the top 25 collaborators of Masja Straetemans. A scholar is included among the top collaborators of Masja Straetemans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masja Straetemans. Masja Straetemans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Straetemans, Masja, et al.. (2025). Determinants of health seeking behaviour in South Sudan: a cross-sectional household survey. BMC Public Health. 25(1). 46–46. 2 indexed citations
2.
Sempa, Joseph B., Rutuja Patil, Masja Straetemans, et al.. (2024). Aligning the principles and practice of research integrity and research fairness in global health: a mixed-methods study. BMJ Global Health. 9(3). e013917–e013917. 3 indexed citations
3.
Alba, Sandra & Masja Straetemans. (2021). Whatever can go wrong, need not go wrong: Open Quality approach for epidemiology. Emerging Themes in Epidemiology. 18(1). 2 indexed citations
4.
Alba, Sandra, Kristien Verdonck, Annick Lenglet, et al.. (2020). Bridging research integrity and global health epidemiology (BRIDGE) statement: guidelines for good epidemiological practice. BMJ Global Health. 5(10). e003236–e003236. 16 indexed citations
5.
Qadeer, Ejaz, Razia Fatima, Aashifa Yaqoob, et al.. (2016). Population Based National Tuberculosis Prevalence Survey among Adults (>15 Years) in Pakistan, 2010–2011. PLoS ONE. 11(2). e0148293–e0148293. 49 indexed citations
6.
Straetemans, Masja, et al.. (2015). Randomized Single-Blinded Non-inferiority Trial Of 7 mg/kg Pentamidine Isethionate Versus 4 mg/kg Pentamidine Isethionate for Cutaneous Leishmaniaisis in Suriname. PLoS neglected tropical diseases. 9(3). e0003592–e0003592. 8 indexed citations
8.
Goris, Marga G. A., Masja Straetemans, Sandra Alba, et al.. (2013). Towards the Burden of Human Leptospirosis: Duration of Acute Illness and Occurrence of Post-Leptospirosis Symptoms of Patients in The Netherlands. PLoS ONE. 8(10). e76549–e76549. 39 indexed citations
9.
Monteilh, Carolyn, Joshua G. Schier, Martin Belson, et al.. (2013). Fentanyl-associated Fatalities Among Illicit Drug Users in Wayne County, Michigan (July 2005–May 2006). Journal of Medical Toxicology. 9(1). 106–115. 61 indexed citations
10.
Bogaart, Erika van den, Emily R. Adams, Pètra F. Mens, et al.. (2012). Prevalence, Features and Risk Factors for Malaria Co-Infections amongst Visceral Leishmaniasis Patients from Amudat Hospital, Uganda. PLoS neglected tropical diseases. 6(4). e1617–e1617. 34 indexed citations
11.
Hest, Rob van, Csaba Ködmön, Suzanne Verver, et al.. (2012). Tuberculosis treatment outcome monitoring in European Union countries: systematic review. European Respiratory Journal. 41(3). 635–643. 26 indexed citations
12.
Haas, Walter, Masja Straetemans, G Pfaff, & A Nicoll. (2009). Wie groß sind die Differenzen zwischen den europäischen Pandemieplänen, sind sie relevant und woher stammen sie?. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 52(2). 193–202. 1 indexed citations
13.
Straetemans, Masja, Lee‐Yang Wong, Mary Jean Brown, et al.. (2008). Risk factors for elevated blood lead levels among African refugee children in New Hampshire, 2004. Environmental Research. 108(3). 404–412. 16 indexed citations
14.
Denny, Justin, John Threlfall, Johanna Takkinen, et al.. (2007). Multinational Salmonella Paratyphi B variant Java (Salmonella Java) outbreak, August – December 2007. Weekly releases (1997–2007). 12(51). E071220.2–E071220.2. 29 indexed citations
15.
Straetemans, Masja, Udo Buchholz, Sabine Reiter, Walter Haas, & Gérard Krause. (2007). Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review. BMC Public Health. 7(1). 236–236. 36 indexed citations
16.
Straetemans, Masja, Niels van Heerbeek, Elisabeth A. M. Sanders, et al.. (2005). Immune Status and Eustachian Tube Function in Recurrence of Otitis Media With Effusion. Archives of Otolaryngology - Head and Neck Surgery. 131(9). 771–771. 11 indexed citations
17.
Straetemans, Masja, et al.. (2004). Pneumococcal vaccines for preventing otitis media (Review). 33 indexed citations
18.
Straetemans, Masja, et al.. (2003). Meconium-stained amniotic fluid is not a risk factor for otitis media. European Archives of Oto-Rhino-Laryngology. 260(8). 432–435. 5 indexed citations
19.
Straetemans, Masja, Arto A. Palmu, Kari Auranen, Gerhard A. Zielhuis, & Terhi Kilpi. (2003). The effect of a pneumococcal conjugate vaccine on the risk of otitis media with effusion at 7 and 24 months of age. International Journal of Pediatric Otorhinolaryngology. 67(11). 1235–1242. 19 indexed citations
20.
Straetemans, Masja, Niels van Heerbeek, E.L.G.M. Tonnaer, et al.. (2001). A comprehensive model for the aetiology of otitis media with effusion. Medical Hypotheses. 57(6). 784–791. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026